Schonherz Todd's Form 4 filing
American Oncology Network, Inc. (AONC) · filed May 30, 2024
- Accession no.
- 0001839998-24-000049
- Filed
- May 30, 2024
- Trade date
- May 21, 2024
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.96K. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schonherz ToddCIK 0001984188 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | Class A Common Stock | PPurchaseAcquired | +4,000 | $1.87 | +$7,480 | 4,000 | Direct | |
| May 21, 2024 | Class A Common Stock | PPurchaseAcquired | +1,000 | $1.85 | +$1,850 | 5,000 | Direct | |
| May 21, 2024 | Class A Common Stock | PPurchaseAcquired | +340 | $1.86 | +$632.4 | 5,340 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.